Your browser doesn't support javascript.
Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
Youk, Jeonghwan; Kim, Taewoo; Evans, Kelly V; Jeong, Young-Il; Hur, Yongsuk; Hong, Seon Pyo; Kim, Je Hyoung; Yi, Kijong; Kim, Su Yeon; Na, Kwon Joong; Bleazard, Thomas; Kim, Ho Min; Fellows, Mick; Mahbubani, Krishnaa T; Saeb-Parsy, Kourosh; Kim, Seon Young; Kim, Young Tae; Koh, Gou Young; Choi, Byeong-Sun; Ju, Young Seok; Lee, Joo-Hyeon.
  • Youk J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea; GENOME INSIGHT, Inc., Daejeon 34051, Republic of Korea.
  • Kim T; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
  • Evans KV; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 A0W, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EL, UK.
  • Jeong YI; Division of Viral Disease Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea.
  • Hur Y; BioMedical Research Center, Korea Advanced institute of Science and Technology, Daejeon 34141, Republic of Korea.
  • Hong SP; Center for Vascular Research, Institute for Basic Science, Daejeon 34126, Republic of Korea.
  • Kim JH; Division of Viral Disease Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea.
  • Yi K; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
  • Kim SY; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
  • Na KJ; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul 03080, Republic of Korea.
  • Bleazard T; The National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.
  • Kim HM; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea; Center for Biomolecular and Cellular Structure, Institute for Basic Science, Daejeon 34126, Republic of Korea.
  • Fellows M; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Mahbubani KT; Department of Surgery and Cambridge NIHR Biomedical Research Centre, Biomedical Campus, University of Cambridge, Cambridge CB2 2QQ, UK.
  • Saeb-Parsy K; Department of Surgery and Cambridge NIHR Biomedical Research Centre, Biomedical Campus, University of Cambridge, Cambridge CB2 2QQ, UK.
  • Kim SY; Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon 35015, Republic of Korea.
  • Kim YT; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul 03080, Republic of Korea. Electronic address: ytkim@snu.ac.kr.
  • Koh GY; Center for Vascular Research, Institute for Basic Science, Daejeon 34126, Republic of Korea. Electronic address: gykoh@kaist.ac.kr.
  • Choi BS; Division of Viral Disease Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea. Electronic address: byeongsun@korea.kr.
  • Ju YS; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea; GENOME INSIGHT, Inc., Daejeon 34051, Republic of Korea. Electronic address: ysju@kaist.ac.kr.
  • Lee JH; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 A0W, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EL, UK. Electronic address: jhl62@cam.ac.uk.
Cell Stem Cell ; 27(6): 905-919.e10, 2020 12 03.
Article in English | MEDLINE | ID: covidwho-885442
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the cause of a present pandemic, infects human lung alveolar type 2 (hAT2) cells. Characterizing pathogenesis is crucial for developing vaccines and therapeutics. However, the lack of models mirroring the cellular physiology and pathology of hAT2 cells limits the study. Here, we develop a feeder-free, long-term, three-dimensional (3D) culture technique for hAT2 cells derived from primary human lung tissue and investigate infection response to SARS-CoV-2. By imaging-based analysis and single-cell transcriptome profiling, we reveal rapid viral replication and the increased expression of interferon-associated genes and proinflammatory genes in infected hAT2 cells, indicating a robust endogenous innate immune response. Further tracing of viral mutations acquired during transmission identifies full infection of individual cells effectively from a single viral entry. Our study provides deep insights into the pathogenesis of SARS-CoV-2 and the application of defined 3D hAT2 cultures as models for respiratory diseases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Alveoli / Stem Cells / SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Cell Stem Cell Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Alveoli / Stem Cells / SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Cell Stem Cell Year: 2020 Document Type: Article